BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27345612)

  • 1. Is diffusion-weighted MRI sufficient for follow-up of neuroendocrine tumour liver metastases?
    Lavelle LP; O'Neill AC; McMahon CJ; Cantwell CP; Heffernan EJ; Malone DE; Daly L; Skehan SJ
    Clin Radiol; 2016 Sep; 71(9):863-8. PubMed ID: 27345612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement variability of liver metastases from neuroendocrine tumors on different magnetic resonance imaging sequences.
    Lestra T; Kanagaratnam L; Mulé S; Janvier A; Brixi H; Cadiot G; Dohan A; Hoeffel C
    Diagn Interv Imaging; 2018 Feb; 99(2):73-81. PubMed ID: 29339222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine liver metastases: Value of apparent diffusion coefficient and enhancement ratios for characterization of histopathologic grade.
    Besa C; Ward S; Cui Y; Jajamovich G; Kim M; Taouli B
    J Magn Reson Imaging; 2016 Dec; 44(6):1432-1441. PubMed ID: 27227756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration.
    Luersen GF; Wei W; Tamm EP; Bhosale PR; Szklaruk J
    J Comput Assist Tomogr; 2016; 40(5):717-22. PubMed ID: 27636124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
    Hayoz R; Vietti-Violi N; Duran R; Knebel JF; Ledoux JB; Dromain C
    Eur Radiol; 2020 Dec; 30(12):6593-6602. PubMed ID: 32601948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
    Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS
    Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging.
    d'Assignies G; Fina P; Bruno O; Vullierme MP; Tubach F; Paradis V; Sauvanet A; Ruszniewski P; Vilgrain V
    Radiology; 2013 Aug; 268(2):390-9. PubMed ID: 23533288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of acquired diffusion weighted imaging and computed diffusion weighted imaging for detection of hepatic metastases.
    Shimizu H; Isoda H; Fujimoto K; Kawahara S; Furuta A; Shibata T; Togashi K
    Eur J Radiol; 2013 Mar; 82(3):453-8. PubMed ID: 23182960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
    Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
    J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
    Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA
    Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low b-value (50-100) diffusion-weighted images detect significantly more hyperintense liver lesions in children than T2-weighted images.
    Grasparil ADI; Gupta H; Sheybani E; Chavhan GB
    Pediatr Radiol; 2019 Sep; 49(10):1299-1305. PubMed ID: 31292681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted magnetic resonance imaging of the liver using tracking only navigator echo: feasibility study.
    Takahara T; Kwee TC; Van Leeuwen MS; Ogino T; Horie T; Van Cauteren M; Herigault G; Imai Y; Mali WP; Luijten PR
    Invest Radiol; 2010 Feb; 45(2):57-63. PubMed ID: 20057318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurements of Hepatic Metastasis on MR Imaging:: Assessment of Interobserver and Intersequence Variability.
    Karademir I; Ward E; Peng Y; Wise L; Buckle C; Kunnavakkam R; Oto A
    Acad Radiol; 2016 Feb; 23(2):132-43. PubMed ID: 26548855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of monopolar and bipolar diffusion weighted imaging sequences for detection of small hepatic metastases.
    Furuta A; Isoda H; Yamashita R; Ohno T; Kawahara S; Shimizu H; Shibata T; Togashi K
    Eur J Radiol; 2014 Sep; 83(9):1626-30. PubMed ID: 24998079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal tumour volume (GTV) delineation using T2-weighted and diffusion-weighted MRI: Implications for radiotherapy planning.
    Regini F; Gourtsoyianni S; Cardoso De Melo R; Charles-Edwards GD; Griffin N; Parikh J; Rottenberg G; Leslie M; Gaya A; Goh V
    Eur J Radiol; 2014 May; 83(5):768-72. PubMed ID: 24646719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
    Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
    J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted imaging of the liver in patients with chronic liver disease: comparison of monopolar and bipolar diffusion gradients for image quality and lesion detection.
    Lewis S; Kamath A; Chatterji M; Patel A; Shyknevsky I; Dyvorne HA; Kuehn B; Taouli B
    AJR Am J Roentgenol; 2015 Jan; 204(1):59-68. PubMed ID: 25539238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal Phase of Dynamic Computed Tomography for Reliable Size Measurement of Metastatic Neuroendocrine Tumors of the Liver: Comparison between Pre- and Post-Contrast Phases.
    Huh J; Park J; Kim KW; Kim HJ; Lee JS; Lee JH; Jeong YK; Shinagare AB; Ramaiya NH
    Korean J Radiol; 2018; 19(6):1066-1076. PubMed ID: 30386138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted imaging during MR-guided radiofrequency ablation of hepatic malignancies: analysis of immediate pre- and post-ablative diffusion characteristics.
    Hoffmann R; Rempp H; Schraml C; Schwenzer N; Grözinger G; Blumenstock G; Rothgang E; Pereira PL; Claussen CD; Clasen S
    Acta Radiol; 2015 Aug; 56(8):908-16. PubMed ID: 25182804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of measurement of apparent diffusion coefficients of malignant hepatic tumors: effect of DWI techniques and calculation methods.
    Kim SY; Lee SS; Park B; Kim N; Kim JK; Park SH; Byun JH; Song KJ; Koo JH; Choi EK; Lee MG
    J Magn Reson Imaging; 2012 Nov; 36(5):1131-8. PubMed ID: 22777895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.